# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed May 18, 2018

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2018-05-18
- Accepted by EDGAR: May 18, 2018, 20:07 ET
- Period: 2018-05-17
- Accession: 0000875320-18-000016
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532018000016/a8-k2018annualmeeting.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532018000016/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532018000016/a8-k2018annualmeeting.htm

Filed May 18, 2018.
Source: SEC EDGAR, the filing index for accession 0000875320-18-000016. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.